Identification of circulating microRNAs as biomarkers in cancers: what have we got?

被引：25
|
作者：
Sun, Yu [1 ]
Zhang, Kuo [1 ]
Fan, Gaowei [1 ,2 ]
Li, Jinming [1 ,2 ]
机构：
[1] Beijing Hosp, Natl Ctr Clin Labs, Minist Hlth, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2012年 / 50卷 / 12期
关键词：
biomarkers; cancer; circulating microRNAs; confounding factors; BREAST-CANCER; OVARIAN-CANCER; SERUM; PLASMA; EXPRESSION; DIAGNOSIS; RNAS;
D O I：
10.1515/cclm-2012-0360
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
During the past few years there has been great interest in the development of circulating microRNAs (miRNAs) as stable blood-based biomarkers for cancer detection. Deregulation of miRNAs in blood samples has shown considerable clinical utilities in cancers. Due to poorly characterized preanalytical and analytical variables and the lack of a standardized measurement protocol, the application of these miRNA fingerprints is hindered by conflicting results. In this review, we outline our current understanding of preanalytically and analytically confounding factors. We believe that great consideration should be taken in the development of circulating miRNA as tumor biomarkers.
引用
收藏
页码：2121 / 2126
页数：6
相关论文
共 50 条
  • [41] New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers
    Zavesky, L.
    Jandakova, E.
    Turyna, R.
    Langmeierova, L.
    Weinberger, V.
    Minar, L.
    Kohoutova, M.
    NEOPLASMA, 2015, 62 (04) : 509 - 520
  • [42] Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol
    Elmira Gheytanchi
    Zahra Madjd
    Leila Janani
    Arezoo Rasti
    Roya Ghods
    Fatemeh Atyabi
    Mohammad Hossein Asadi-Lari
    Sadegh Babashah
    Systematic Reviews, 6
  • [43] We asked for what we got
    Enos, GA
    BEHAVIORAL HEALTHCARE TOMORROW, 2002, 11 (03): : 6 - 6
  • [44] HAVE WE GOT PDM WE DESERVE
    不详
    MECHANICAL HANDLING INTERNATIONAL, 1974, 61 (04): : 29 - 29
  • [45] WHAT HAVE THEY GOT TO HIDE
    不详
    NEW SCIENTIST, 1995, 147 (1996) : 3 - 3
  • [46] JAPAN NEW TRADE SECRET LAW - WE ASKED FOR IT - NOW WHAT HAVE WE GOT
    SVETZ, HE
    GEORGE WASHINGTON JOURNAL OF INTERNATIONAL LAW AND ECONOMICS, 1992, 26 (02): : 413 - 449
  • [47] Dietary polyphenols for managing cancers: What have we ignored?
    Wu, Xu
    Li, Mingxing
    Xiao, Zhangang
    Daglia, Maria
    Dragan, Simona
    Delmas, Dominique
    Vong, Chi Teng
    Wang, Yitao
    Zhao, Yueshui
    Shen, Jing
    Nabavi, Seyed Mohammad
    Sureda, Antoni
    Cao, Hui
    Simal-Gandara, Jesus
    Wang, Mingfu
    Sun, Chongde
    Wang, Shengpeng
    Xiao, Jianbo
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2020, 101 (101) : 150 - 164
  • [48] MicroRNAs as Potential Biomarkers in Gynecological Cancers
    Miskiewicz, Joanna
    Mielczarek-Palacz, Aleksandra
    Gola, Joanna Magdalena
    BIOMEDICINES, 2023, 11 (06)
  • [49] Hunting for medical errors: asking 'What have we got wrong today?'
    Launer, John
    POSTGRADUATE MEDICAL JOURNAL, 2017, 93 (1104) : 643 - 644
  • [50] A SNEAK PEEK AT THE FUTURE OF WHAT WE HAVE GOT USED TO CALLING (A) LANGUAGE
    Rajagopalan, Kanavillil
    CADERNOS DE ESTUDOS LINGUISTICOS, 2023, 65
12345